Contracts › 75F40126F80158
75F40126F80158: Ocs Meddra-Based Adverse Event Diagnostics (MAED) Annual Support
Awarded to Index Analytics Llc by Food and Drug Administration (FDA).
$1.2Mobligated
$1.2Mpotential value
11 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40126F80158 |
|---|---|
| Vehicle | 75N98118D00049 |
| Awardee | Index Analytics Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541512 Computer Systems Design Services |
| PSC | DH01 It and Telecom - Platform Support Services: Database, Mainframe, Middleware (Labor) |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 04 September 2026 to 11 September 2027 |
| Potential end | 11 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541512 contracts · All expiring contracts · USASpending record